CryoPort PE Ratio 2010-2024 | CYRX
Current and historical p/e ratio for CryoPort (CYRX) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CryoPort PE ratio as of November 21, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CryoPort PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-11-20 |
6.57 |
|
0.00 |
| 2024-09-30 |
8.11 |
$-3.38 |
0.00 |
| 2024-06-30 |
6.91 |
$-3.67 |
0.00 |
| 2024-03-31 |
17.70 |
$-2.47 |
0.00 |
| 2023-12-31 |
15.49 |
$-2.20 |
0.00 |
| 2023-09-30 |
13.71 |
$-1.13 |
0.00 |
| 2023-06-30 |
17.25 |
$-0.97 |
0.00 |
| 2023-03-31 |
24.00 |
$-0.78 |
0.00 |
| 2022-12-31 |
17.35 |
$-0.93 |
0.00 |
| 2022-09-30 |
24.36 |
$-6.15 |
0.00 |
| 2022-06-30 |
30.98 |
$-6.18 |
0.00 |
| 2022-03-31 |
34.91 |
$-6.11 |
0.00 |
| 2021-12-31 |
59.17 |
$-5.93 |
0.00 |
| 2021-09-30 |
66.51 |
$-1.79 |
0.00 |
| 2021-06-30 |
63.10 |
$-1.90 |
0.00 |
| 2021-03-31 |
52.01 |
$-1.89 |
0.00 |
| 2020-12-31 |
43.88 |
$-1.87 |
0.00 |
| 2020-09-30 |
47.40 |
$-0.58 |
0.00 |
| 2020-06-30 |
30.25 |
$-0.64 |
0.00 |
| 2020-03-31 |
17.07 |
$-0.57 |
0.00 |
| 2019-12-31 |
16.46 |
$-0.54 |
0.00 |
| 2019-09-30 |
16.36 |
$-0.59 |
0.00 |
| 2019-06-30 |
18.32 |
$-0.31 |
0.00 |
| 2019-03-31 |
12.92 |
$-0.32 |
0.00 |
| 2018-12-31 |
11.03 |
$-0.34 |
0.00 |
| 2018-09-30 |
12.81 |
$-0.35 |
0.00 |
| 2018-06-30 |
15.78 |
$-0.36 |
0.00 |
| 2018-03-31 |
8.60 |
$-0.35 |
0.00 |
| 2017-12-31 |
8.59 |
$-0.35 |
0.00 |
| 2017-09-30 |
9.85 |
$-0.51 |
0.00 |
| 2017-06-30 |
4.92 |
$-0.57 |
0.00 |
| 2017-03-31 |
2.36 |
$-0.77 |
0.00 |
| 2016-12-31 |
3.24 |
$-0.93 |
0.00 |
| 2016-09-30 |
1.97 |
$-1.10 |
0.00 |
| 2016-06-30 |
2.08 |
$-1.37 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Transportation |
Transportation - Services |
$0.322B |
$0.233B |
|
CryoPort, Inc. operates as a provider of shipping solutions comprising cold chain frozen shipping system for transporting biological, environmental and other temperature sensitive materials at temperatures below minus 150? Celsius. Its products include CryoPort Express Shippers, cryogenic dry vapor shippers capable of maintaining cryogenic temperatures; biological material holders for the shipment of infectious or dangerous goods; CryoPort Express System to programmatically manage order entry and various aspects of shipping operations; and CryoPort Express Analytics, to monitor shipment performance metrics and to evaluate temperature-monitoring data collected by the data logger during shipment. The Company's products find their application in the transportation of live cell pharmaceutical products, such as cancer vaccines, diagnostic materials, semen and embryos, and infectious substances. CryoPort, Inc. is based in Lake Forest, California.
|
